Skip to Content

Generic Adrenaclick Availability

Last updated on Sep 8, 2021.

Adrenaclick is a brand name of epinephrine, approved by the FDA in the following formulation(s):

ADRENACLICK (epinephrine - injectable;intramuscular, subcutaneous)

  • Manufacturer: IMPAX
    Approval date: November 25, 2009
    Strength(s): EQ 0.15MG/DELIVERY [RLD] [BX], EQ 0.3MG/DELIVERY [RLD] [BX]

Has a generic version of Adrenaclick been approved?

An Authorized Generic version of Adrenaclick has been approved. An Authorized Generic is a prescription drug that is produced by a brand company under a New Drug Application (NDA) and marketed as a generic under a private label. It is identical to the branded product in appearance and has exactly the same inactive ingredients.

List of authorized generic versions:

  • epinephrine SUBCUTANEOUS INJECTION .3 mg/.3mL
    Amneal Pharmaceuticals of New York LLC
    NDC Code: 001151694
  • epinephrine SUBCUTANEOUS INJECTION .15 mg/.15mL
    Amneal Pharmaceuticals of New York LLC
    NDC Code: 001151695
  • epinephrine SUBCUTANEOUS INJECTION .3 mg/.3mL
    AvKARE
    NDC Code: 422910425
  • epinephrine SUBCUTANEOUS INJECTION .3 mg/.3mL
    A-S Medication Solutions
    NDC Code: 500903155
  • epinephrine SUBCUTANEOUS INJECTION .3 mg/.3mL
    A-S Medication Solutions
    NDC Code: 500904506
  • EPINEPHRINE SUBCUTANEOUS INJECTION .15 mg/.15mL
    HF Acquisition Co LLC, DBA HealthFirst
    NDC Code: 516621222
  • EPINEPHRINE SUBCUTANEOUS INJECTION .3 mg/.3mL
    HF Acquisition Co LLC, DBA HealthFirst
    NDC Code: 516621223
  • epinephrine SUBCUTANEOUS INJECTION .3 mg/.3mL
    REMEDYREPACK INC.
    NDC Code: 705182048
  • epinephrine SUBCUTANEOUS INJECTION .15 mg/.15mL
    Medical Purchasing Solutions, LLC
    NDC Code: 718727007
  • epinephrine SUBCUTANEOUS INJECTION .3 mg/.3mL
    Medical Purchasing Solutions, LLC
    NDC Code: 718727103

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Adrenaclick. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: Generic Drug FAQ.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Medicine injection apparatuses
    Patent 10,166,334
    Issued: January 1, 2019
    Assignee(s): Washington Biotech Corporation

    A medicine injector in which a barrel with a receiving cavity is adapted to slidably receive a syringe subassembly for axial movement therein. Upon removal of a safety and release of a syringe driver, the syringe driver moves forward and injects the syringe needle. Penetration controls are shown for controlling needle penetration depth. In one form the penetration control uses a sleeve and spring which are radially adjacent. A cushioning ring or other cushion may be used to reduce syringe breakage. A load distribution and guide ring may be used to distribute loading applied to the syringe and help guide the moving syringe.

    Patent expiration dates:

    • January 21, 2025
      ✓ 
      Drug product
  • Kits containing medicine injection devices and containers
    Patent 7,905,352
    Issued: March 15, 2011
    Inventor(s): Wyrick; Ronald E.
    Assignee(s): Washington Biotech Corporation

    A reloadable medicine injector and methods are described in which a barrel with a receiving cavity is adapted to slidably receive a syringe subassembly for axial movement therein. Upon removal of a safety and release of a syringe driver, the syringe driver moves forward and injects the syringe needle. A plurality of penetration controls are shown for controlling injection needle penetration depth. The penetration controls have an abutment and various lengths to provide different needle penetration depth positions. In one form of penetration control a sleeve is used against which the syringe or related parts contact. In another form the front return spring is used as a penetration control. A cushioning ring may be used to reduce syringe breakage. A load distribution and guide ring may be used to distribute loading applied to the syringe and help guide the moving syringe.

    Patent expiration dates:

    • April 12, 2027
      ✓ 
      Drug product

Glossary

Term Definition
Drug Patent A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.
Drug Exclusivity Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant.
RLD A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.